Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Levcromakalim submitted for Japanese regulatory approval

May 17, 1996

Shionogi and BMS to collaborate on irbesartan

May 17, 1996

New angiotensin II antagonist presented by Bayer at German pharmacology meeting

May 17, 1996

Endothelin antagonists reported by Shionogi

May 17, 1996

Advisory committee refuses to recommend Coreg approval for CHF

May 10, 1996

Structure revealed for UK-1745

May 10, 1996

Structure disclosed for KCB-328

May 10, 1996

More Na+/H+-exchange inhibitors from Hoechst

May 10, 1996

Na+/H+-exchange inhibitors revealed by E. Merck

May 10, 1996

Cylexin phase II results announced

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...